NGS has been on a fascinating journey, featuring numerous pioneering players all racing to get their technology to market. A little over 20 years ago, the race began…
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
There are countless benefits to companion diagnostics including better evidence of clinical utility & greater patient access, more efficient use of resources, better safety and economic advantages for drug companies.
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
With a new home, the Minicare I-20 will cement its place as the market leader. As always, this extra competition will encourage innovation among competitors.
Lessons in lateral flow don't come much better than from a founding father of the technology. That's just what we got by speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic.
It’s hard to estimate the total size and value of the diagnostics market, however by looking at some of the forecasts available, the scale of the industry is evident.
Whether you call it a lateral flow test, dipstick, rapid test or test strip, they’re all different names for the same sort of test that, in the past, has acquired a somewhat unfair reputation for being too simplistic.
In the world of in vitro diagnostics, there’s nowhere more exciting than Asia. To put it into context, in the period between 2017 and 2022, the North American IVD market is expected to grow from $31.1B to $36.9B,but the Asian market over the same...
